Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Investigation of Definitive Targeted Therapy for Solid Malignancies With Oligometastases

NCT01898962 is registered in ClinicalTrials.gov with Rocky Mountain Cancer Centers as lead sponsor.

NCT NCT01898962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01898962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Investigation of Definitive Targeted Therapy for Solid Malignancies With Oligometastases
Lead sponsor
Rocky Mountain Cancer Centers
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2005
Completion date
December 31, 2018
Enrollment
110 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv or recurrent carcinoma or sarcoma